PierianDx
1005 North Warson Road, Suite 401
St. Louis
Missouri
63132
United States
Website: http://pieriandx.com/
31 articles about PierianDx
-
PierianDx and Biodesix Partner to Advance Lung Cancer Diagnostics
1/19/2022
PierianDx, the global leader in clinical genomics knowledge, announced that it has partnered with Biodesix to provide its interpretation technology platform for use with the Biodesix newly launched GeneStrat NGS™ genomic test, a blood-based tumor profiling test to detect actionable mutations in patients with non-small cell lung cancer.
-
PierianDx Closes up to $47.5 Million of Growth Capital
11/2/2021
PierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to additional tranches for up to $17.5 million by 2022 and 2023, subject to certain conditions.
-
PierianDx Partners with Florida Cancer Specialists & Research Institute to Advance Cancer Care
10/7/2021
PierianDx, the global leader in clinical genomics knowledge, announced that it will partner with Florida Cancer Specialists & Research Institute to support expanded access to the highest quality genomic testing on solid tumors and hematologic malignancies and lymph nodes leveraging NGS technology.
-
PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets
12/1/2020
PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq™ for Illumina ® Focus Panel, AmpliSeq™ for Illumina ® Myeloid Panel and the TruSight™ Hereditary Cancer
-
PierianDx and Bench International Announce the Appointment of Mark McDonough as New CEO
11/17/2020
PierianDx, the leading clinical genomics informatics company, and Bench International, a leading global executive search firm, jointly announce the appointment of Mark McDonough as Chief Executive Officer (CEO) and member of the Board of Directors of PierianDx, effective immediately.
-
PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care
10/14/2020
PierianDx, the leading clinical genomics informatics company, and Pillar Biosciences, a leading next-generation sequencing clinical oncology company, today announced a partnership that enables Pillar Biosciences to sell directly the PierianDx cli
-
Intermountain Healthcare Selects PierianDx Clinical Genomics Solution
12/11/2019
PierianDx, the leading clinical genomics informatics company, today announced that Intermountain Healthcare has selected the PierianDx Clinical Genomics Workstation to advance their precision medicine program, Intermountain Precision Genomics.
-
PierianDx Closes Series B Financing Round to Facilitate the Democratization of Clinical Next-Generation Sequencing
10/28/2019
Funding led by ATW Partners and SJF Ventures with follow-on Investment from Health Catalyst Capital, RTI International, and Inova Health Systems
-
PierianDx Announces Multi-Year Agreement with Illumina to Support Cancer Research and Diagnostics
1/4/2019
PierianDx, a leading clinical genomics informatics company, today announced a strategic, non-exclusive, multi-year partnership with Illumina, Inc. to provide a variant interpretation and reporting solution based on PierianDx’s Clinical Genomics Workspace platform and Clinical Genomics Knowledgebase for select Illumina oncology products.
-
PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International
4/17/2018
PierianDx, the leading genomics technology company that enables precision medicine, announced today a strategic partnership with RTI International to help solve the problem of translating complex genomic data into actionable clinical insight to advance precision medicine.
-
PierianDx Showcases Germline Capabilities of its Clinical Genomics WorkSpace™ (CGW) Platform at ACMG 2018
4/12/2018
PierianDx, the leading genomics technology company that enables precision medicine, announced at the annual meeting of the American College of Medical Genetics and Genomics (ACMG) a series of enhanced germline testing features for the company’s enterprise informatics software platform.
-
PierianDx Announces Partnership with Cancer Genetics to Provide Comprehensive Precision Oncology Testing and Workflow Solution
3/14/2018
CGI is a leader in enabling precision medicine for oncology through molecular markers and diagnostics.
-
PierianDx Launches Clinical Genomics Services to Accelerate Precision Medicine
3/8/2018
PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption of the company’s enterprise software platform, the Clinical Genomics WorkSpace (CGW).
-
PierianDx Hosts Expert Customer Panel Discussion Regarding Debated CMS National Coverage Decision on NGS Testing
2/14/2018
PierianDx announced today it will be hosting an expert panel to discuss CMS’s National Coverage Decision (NCD) on clinical tests that limit the coverage to FDA-approved NGS tests with companion diagnostic indications.
-
PierianDx Names New Additions to Sales and Clinical Genomic Solutions Teams
10/26/2017
PierianDx announced today two key additions that will expand the organization’s reach into health systems and global markets while deepening clinical expertise.
-
Cleveland Clinic Joins PierianDx's Customer Network To Accelerate Precision Medicine
10/18/2017
PierianDx announced today that Cleveland Clinic will utilize its integrated "one space" workflow and analysis solution, Clinical Genomicist Workspace (CGW), to advance precision medicine for patients.
-
PierianDx Accelerates Precision Medicine With Fully Integrated Workflow And Interpretation Solution Supporting Illumina Trusight Tumor 170
10/11/2017
-
PierianDx Announces Clinical Microarray Technology Will Be Integrated Into Its End-To-End Genomics Platform For Clinical Labs
9/22/2017
-
PierianDx Release: Moffitt Cancer Center Showcases Its Blueprint For Building A Best-In-Class Precision Medicine Program At Pieriandx-Hosted Webinar
9/11/2017
-
PierianDx Announces Launch Of Clinical Interpretation Services At ACMG 2017; New Service Combines Powerful Technology With Medical And Scientific Expertise
3/23/2017